Edited by blastoff at 27-7-2021 09:19 AM
Nampak graf pada 25 julai 2021 bawah ni yg landai je tuuuuu, 3 kes sajaaaa. Itu terkini le tu, isu semasa la tuuu. Penduduk Uttar Pradesh keseluruhan adalah 234 jutaa maaa tapi mampu hapuskan pandemik totally dgn hanya guna ivermectin .
Sementara kat malaysia nak kawal kes baru dari berlaku lagi dan lagi dan lagi yg dalam penjara sebesar kangkang keraaa tuu punggg gagal kaw kaw
Pada bulan april, kes baru covid 19 mencecah 36605 di uttar pradesh , tapi selepas guna ivermectin , jadi 3 je kes baru lani, ish ish ish kenapa laaa Malaysia buat2 butaaa ye pada kejayaan Uttar Pradesh membenteras wabak covid 19 itteww guna ivermectin ?
Kroni2 nak cari makan kat malaysia tak leh kalau berjaya kawal covid 19 kerana bisnes PPE , ubat steroid dexamethasone dan prednisolone dan vaksin , catering pusat kuarantin, kerja sanitasi, botol oksigen , gloves , mask , errr bisnes semua tuuu kang rugi teruk laaa kalau pandemik dah tak wujud kannn, so perlu di hindari guna ivermectin ler agar seramai mungkin maut pung tak pe sebab poket kroni2 perlu hidup segar bugar kekdahnya, nyawa manusia cuma collateral damage, perlu di sacrifice kekdahnyaaa utk kebahagiaan kroni2.
Nampak artikel bawah tuu, rupa2 nyaaa ivermectin adalah anti viral, anti parasitic, anti cancer dan anti HIV , ada 4 ciri pada ivermectin yg menyebabkan bigpharma macam pfizer tu anti sesgt lah dgn ubat nih kerana agenda kanserkan yg ambik vaksin nyaa tu bakal kantoi kaw kaw ler kalau semua guna ivermectin utk kawal pandemik.
Uttar pradesh guna ivermectin terhadap semua kes mild dan home kuarantin serta contact rapat for prevention of new cases . Yg kes2 kritikal kat spital para doktor yg masih terpengaruh dgn WHO tetap tak mahu guna juga walau ada some of them dah mula beralih ke arah ivermectin.
\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
https://www.google.com/search?q= ... eid=chrome&ie=UTF-8
Bandingkan dgn malaysia, kes baru pada 25 julai 2021 adalah 17,045
\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
https://www.financialexpress.com ... has-to-say/2231596/
Ivermectin, also referred to as a ‘wonder drug’ by many, is usually used to treat parasitic infections like onchocerciasis (river blindness), trichuriasis, scabies, strongyloidiasis, and other diseases caused by soil-transmitted helminthiasis. But, Uttar Pradesh has prescribed it as part of a protocol to treat mild and moderate cases of COVID-19. Moreover, rapid response teams in the state have been ordered to distribute Ivermectin to people under home isolation. The teams of doctors who assess asymptomatic patients are even asking primary and secondary contacts of confirmed cases to take this drug in order to prevent any possible infection. When asked about the decision to continue the usage of the drug for the treatment of COVID-19, Dr Surya Kant Tripathi – Head, Respiratory Medicine Department, King George Medical University, Lucknow – told Financial Express Online that Ivermectin is being used both for the treatment of coronavirus patients and as prophylaxis for COVID-19 for more than nine months without any major side effects being reported. “The drug is being majorly used for the treatment of COVID-19 when patients are under home isolation and also in all mild cases of the disease. It is true that we have not used the drug in severe cases. But this is also a fact that even healthcare workers shifted from the prophylaxis of hydroxychloroquine to Ivermectin. This is because we observed that 17 per cent of healthcare workers using hydroxychloroquine developed one or another kind of side effects,” Dr Surya Kant – who is also national vice chairman of IMA-AMS – said. India emerging as the next best destination for medical tourism post-COVID-19 pandemic!It must be noted that Dr Surya Kant, along with some other health experts of India, wrote a white paper on Ivermectin last year and it was displayed on the website of the World Health Organization. Dr Surya Kant also emphasized that this drug reduces the replication rate of the infection by several thousand times. It was only after this white paper when Uttar Pradesh government started using the drug. UP was the first state to use Ivermectin for treatment of COVID-19 and it has been extensively used since then, the doctor of KGMU said. “Not only Uttar Pradesh, governments of West Bengal, Maharashtra, and Assam too included Ivermectin in their protocol for the treatment of COVID-19,” he added. When asked about the lack of clinical trial data on Ivermectin, Dr Surya Kant said that over 40 such trials are underway, and not one has reported any major side effects yet. “More than 40 clinical trials are underway, including eight in India. This includes the most prestigious institute in India i.e. AIIMS Delhi. The trial underway at AIIMS is also on five different types of doses of Ivermectin, which is a very important issue. So, all kinds of trials are underway. My whitepaper was published in the month of July 2020. In the whitepaper, 19 Indian experts have contributed. They collected and compiled all data available on Ivermectin since 1981, when the drug was introduced to the world. Both researchers (William C. Campbell of US and Satoshi ōmura from Japan) who discovered this drug won the 2015 Nobel Prize in Physiology or Medicine for discovering this drug. It has got more than four properties – anti-viral, anti-parasitic, anti-cancer, and even anti-HIV. This is a wonderful drug, low cost, widely available and used for last 40 years throughout the world.”
|